Literature DB >> 31507869

Smoking and mental health.

Hamid Ghodse1.   

Abstract

Smoking affects everyone. It is a major cause of death and disability, with five million worldwide dying prematurely each year as a result of smoking. For those who live with smokers, there is a significantly higher risk of developing heart disease or lung cancer. The economic costs are high, too, and billions of pounds are spent each year from National Health Service budgets on treating diseases caused by smoking.

Entities:  

Year:  2007        PMID: 31507869      PMCID: PMC6734746     

Source DB:  PubMed          Journal:  Int Psychiatry        ISSN: 1749-3676


On the face of it, it is difficult to understand why so many people do smoke. Given all the evidence, why don’t they just stop? A full answer to this apparently simple question would involve a complex exploration of pharmacology and an understanding of psychological dependence, but the simple answer is that people smoke because it is extremely difficult to quit. However, quitting is not impossible, and this is borne out by the thousands of smokers who do manage to quit each year, often making use of whatever stop-smoking services are available to them. It is widely acknowledged that smoking is a preventable cause of death and disability. This is reflected in the very large number of signatories to the World Health Organization (WHO) Framework Convention on Tobacco Control, which came into force on 27 February 2005. This is the only convention to have received more than 170 national signatories. It expresses concern about the devastating worldwide health, social, economic and environmental consequences of tobacco consumption and exposure to tobacco smoke, and recognises that the spread of the tobacco epidemic is a global problem with serious consequences for public health. It emphasises the burden being placed on families, on the poor and on national health systems, particularly in low- and middle-income countries, by the increased consumption of tobacco products and it calls for the widest possible international cooperation and the participation of all countries in an effective, appropriate and comprehensive international response (see http://www.who.int/tobacco/framework/en/). This excellent initiative of the WHO, supported by the international community, has moved the issue of smoking cessation up the agenda of health services in many countries, although in some this has been with more urgency than in others. Within this context, there are important and specific implications for those with mental illness, who are a particularly vulnerable group in terms of the effects of smoking. Smoking rates are at least twice as high among people with mental health problems as in the general population (Meltzer et al, 1995), with nearly 45% of all cigarettes consumed being smoked by individuals with a psychiatric disorder (Lasser et al, 2000). One possible explanation is that many mental health patients effectively self-medicate with tobacco, using nicotine to alleviate their symptoms. For example, nicotine has been found to stimulate neurotransmitters (such as dopamine) in the same way that many antidepressant medications do (Le Houezec, 1998). Another theory is that the propensity to smoke among these patients is mediated by their social circumstances. Smoking has been found to be strongly associated with social deprivation in terms of low income, poor accommodation, unemployment and so on (Jarvis & Wardle, 1999), and deprivation, in turn, is related to the presence of psychiatric disorder (Rasul et al, 2001). Contrary to common assumptions, recent surveys in the UK have reported that around half of smokers with mental health problems are concerned about their smoking and want to stop (McNeill, 2001). However, they have expressed dissatisfaction with the support they receive from mental health professionals in relation to quitting. It has been claimed that psychiatrists rarely discuss patients’ smoking and that local services rarely support smoking cessation, for example by offering nicotine replacement therapy. Historically, too, little attention has been paid to the psychiatric patient group in smoking cessation research. In a recent review of the literature on hospital-based smoking cessation (Rigotti et al, 2003), a wide range of healthcare areas were considered but studies of patients admitted with psychiatric disorders were excluded. However, patients with mental health problems have as much right to be helped to overcome their addiction to tobacco as any other individuals and there is, indeed, some evidence to suggest that smoking cessation interventions can be as useful for people with mental health problems as for the rest of the population (El-Guebuly et al, 2002). It is interesting that researchers have reported a sense of exclusion from mainstream cessation programmes among mental health patients (Lawn et al, 2002). Psychiatrists and other members of mental health teams therefore have a particular responsibility to establish policies that will help their patients to quit and to provide individuals with assistance whenever this is needed. The issue of prohibiting smoking in public places has been widely discussed in many countries – and has been implemented in some. Although the adoption of smoke-free policies in healthcare settings is generally a popular move, it is often suggested that psychiatric hospitals should be exempted. This appears to be based on a perception that psychiatric settings are difficult places within which to implement smoking restrictions. This may be related to the unique place occupied by smoking within the practice and culture of psychiatric care. For example, smoking is often a major source of structure and activity to the patient’s day and may also feature strongly in the social club of mental health units (Lawn & Pols, 2005). Studies have also reported that mental health staff often use cigarettes to appease or engage patients (Mester et al, 1993). The arguments for exempting mental health units from smoke-free policies also make reference to human rights, in the context that many patients are resident in hospitals for extended periods and often against their will. Clearly, these are thorny issues. However, mental health patients have the same right as any other patients to access to health promotion and to protection from the harmful effects of smoking. In this complex environment, the attitude of mental health professionals is likely to be of great importance and a recent survey revealed that mental health staff have significantly less positive attitudes towards providing smoking-related intervention to their service users than general medical staff (McNally et al, 2006). There is also some evidence that smoking-related attitudes differ across professional groups. For example, in one study doctors ranked smoking cessation as more important than nurses did (Braun et al, 2004). However, it appears that once smoke-free policies have been in place for some time, staff develop much more positive attitudes towards smoking cessation. This shift in opinion may flow from the fact that smoking bans have rarely been found to lead to increased aggression and adverse incidents and, in fact, have even had a positive effect on ward functioning in many cases (Lawn & Pols, 2005). It is clearly important that patients with psychiatric disorders are not deprived of their right to a smoke-free environment because of unwarranted assumptions about what can and cannot be implemented within a hospital setting. Also, many mental health patients are now cared for in the community, where these arguments are irrelevant. It is therefore essential that psychiatrists exercise their duty of care and leadership in promoting smoking cessation at both individual patient level and within their institutions, to protect their patients from the serious consequences of smoking.
  10 in total

1.  Smoking-related attitudes and clinical practices of medical personnel in Minnesota.

Authors:  Barbara L Braun; Jinnet B Fowles; Leif I Solberg; Elizabeth A Kind; Harry Lando; Donald Pine
Journal:  Am J Prev Med       Date:  2004-11       Impact factor: 5.043

2.  A survey of staff attitudes to smoking-related policy and intervention in psychiatric and general health care settings.

Authors:  Lisa McNally; Adenekan Oyefeso; Jan Annan; Katherine Perryman; Roger Bloor; Steve Freeman; Barbara Wain; Hilary Andrews; Martin Grimmer; Arthur Crisp; Deji Oyebode; A Hamid Ghodse
Journal:  J Public Health (Oxf)       Date:  2006-06-29       Impact factor: 2.341

3.  Smoking and quitting: a qualitative study with community-living psychiatric clients.

Authors:  Sharon J Lawn; Rene G Pols; James G Barber
Journal:  Soc Sci Med       Date:  2002-01       Impact factor: 4.634

4.  Sociodemographic Factors, Smoking and Common Mental Disorder in the Renfrew and Paisley (MIDSPAN) Study.

Authors:  F Rasul; S A Stansfeld; G Davey-Smith; C L Hart; C Gillis
Journal:  J Health Psychol       Date:  2001-03

Review 5.  Nicotine: abused substance and therapeutic agent.

Authors:  J Le Houezec
Journal:  J Psychiatry Neurosci       Date:  1998-03       Impact factor: 6.186

Review 6.  Smoking bans in psychiatric inpatient settings? A review of the research.

Authors:  Sharon Lawn; Rene Pols
Journal:  Aust N Z J Psychiatry       Date:  2005-10       Impact factor: 5.744

7.  Smoking and mental illness: A population-based prevalence study.

Authors:  K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

Review 8.  Interventions for smoking cessation in hospitalised patients.

Authors:  N A Rigotti; M R Munafo; M F Murphy; L F Stead
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 9.  Smoking cessation approaches for persons with mental illness or addictive disorders.

Authors:  Nady El-Guebaly; Janice Cathcart; Shawn Currie; Diane Brown; Susan Gloster
Journal:  Psychiatr Serv       Date:  2002-09       Impact factor: 3.084

10.  Survey of smoking habits and attitudes of patients and staff in psychiatric hospitals.

Authors:  R Mester; P Toren; Y Ben-Moshe; A Weizman
Journal:  Psychopathology       Date:  1993       Impact factor: 1.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.